These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24713091)

  • 1. In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors.
    Ritschel T; Hermans SM; Schreurs M; van den Heuvel JJ; Koenderink JB; Greupink R; Russel FG
    Chem Res Toxicol; 2014 May; 27(5):873-81. PubMed ID: 24713091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors.
    Welch MA; Köck K; Urban TJ; Brouwer KL; Swaan PW
    Drug Metab Dispos; 2015 May; 43(5):725-34. PubMed ID: 25735837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in silico identification of human bile salt export pump (ABCB11) inhibitors associated with cholestatic drug-induced liver injury.
    Xi L; Yao J; Wei Y; Wu X; Yao X; Liu H; Li S
    Mol Biosyst; 2017 Jan; 13(2):417-424. PubMed ID: 28092392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
    Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors.
    Kis E; Ioja E; Nagy T; Szente L; Herédi-Szabó K; Krajcsi P
    Drug Metab Dispos; 2009 Sep; 37(9):1878-86. PubMed ID: 19520776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
    Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
    Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure based classification for bile salt export pump (BSEP) inhibitors using comparative structural modeling of human BSEP.
    Jain S; Grandits M; Richter L; Ecker GF
    J Comput Aided Mol Des; 2017 Jun; 31(6):507-521. PubMed ID: 28527154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
    Cheng Y; Woolf TF; Gan J; He K
    Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.
    Ali I; Khalid S; Stieger B; Brouwer KLR
    Mol Pharm; 2019 Mar; 16(3):1406-1411. PubMed ID: 30608704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function.
    Telbisz Á; Homolya L
    Expert Opin Ther Targets; 2016; 20(4):501-14. PubMed ID: 26573700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions.
    Fattinger K; Funk C; Pantze M; Weber C; Reichen J; Stieger B; Meier PJ
    Clin Pharmacol Ther; 2001 Apr; 69(4):223-31. PubMed ID: 11309550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-speed screening and QSAR analysis of human ATP-binding cassette transporter ABCB11 (bile salt export pump) to predict drug-induced intrahepatic cholestasis.
    Hirano H; Kurata A; Onishi Y; Sakurai A; Saito H; Nakagawa H; Nagakura M; Tarui S; Kanamori Y; Kitajima M; Ishikawa T
    Mol Pharm; 2006; 3(3):252-65. PubMed ID: 16749857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
    Funk C; Ponelle C; Scheuermann G; Pantze M
    Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery.
    Hafey MJ; Houle R; Tanis KQ; Knemeyer I; Shang J; Chen Q; Baudy A; Monroe J; Sistare FD; Evers R
    Drug Metab Dispos; 2020 Nov; 48(11):1147-1160. PubMed ID: 32943412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Concepts in Drug-Induced Bile Salt Export Pump (BSEP) Interference.
    Kenna JG
    Curr Protoc Toxicol; 2014 Aug; 61():23.7.1-15. PubMed ID: 25104267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
    Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
    Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2.
    Mano Y; Usui T; Kamimura H
    Biopharm Drug Dispos; 2007 Jan; 28(1):13-8. PubMed ID: 17061295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
    Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flagging Drugs That Inhibit the Bile Salt Export Pump.
    Montanari F; Pinto M; Khunweeraphong N; Wlcek K; Sohail MI; Noeske T; Boyer S; Chiba P; Stieger B; Kuchler K; Ecker GF
    Mol Pharm; 2016 Jan; 13(1):163-71. PubMed ID: 26642869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.